ADHD
The WSMA encourages physicians to utilize standardized diagnostic criteria
in making the diagnosis of ADHD, such as the current American Psychiatric
Association’s Diagnostic and Statistical Manual, as part of a
comprehensive evaluation of children, adolescents, and adults presenting
with attentional or hyperactivity complaints. (CPA Rpt D, A-97) (Amended
A-23)
The WSMA encourages all relevant residency programs within Washington, and
continuing medical education sponsors to expand educational efforts which
will increase physician knowledge about ADHD, its treatment, and serious
abuse potential of the prescribed medication. (CPA Rpt D, A-97) (Amended
A-23)
The WSMA encourages the use of individualized therapeutic approaches for
children diagnosed with ADHD, which may include pharmacotherapy,
psycho-education, behavioral therapy, school-based and other environmental
interventions, and psychotherapy as indicated by clinical circumstances
and family preferences. (CPA Rpt D, A-97) (Reaffirmed A-23)
The WSMA encourages physicians to work with educators to improve their
ability to recognize ADHD and appropriately recommend that parents seek
medical evaluation of potentially affected children. (CPA Rpt D, A-97)
(Reaffirmed A-23)
The WSMA advocates the use of state funds as grants to programs which
could deliver the non-pharmacologic services for the treatment of ADHD.
(CPA Rpt D, A-97) (Reaffirmed A-23)
Return to the WSMA Policy Compendium index
Abbreviations for House of Delegates report origination:
EC – Executive Committee; BT – Board of Trustees; CPA – Council on
Professional Affairs; JC – Judicial Council; CHS – Community and Health
Services